165 related articles for article (PubMed ID: 37928768)
1. Analysis of Airway Thickening and Serum Cytokines in COPD Patients with Frequent Exacerbations: A Heart of the Matter.
Lin Y; Sang L; Wang J; Chen Y; Lai J; Zhu X; Yang Y; Zhang Z; Liu Y; Wen S; Zhang N; Zhao D
Int J Chron Obstruct Pulmon Dis; 2023; 18():2353-2364. PubMed ID: 37928768
[TBL] [Abstract][Full Text] [Related]
2. Serum Amyloid A in Stable COPD Patients is Associated with the Frequent Exacerbator Phenotype.
Zhao D; Abbasi A; Rossiter HB; Su X; Liu H; Pi Y; Sang L; Zhong W; Yang Q; Guo X; Zhou Y; Li T; Casaburi R; Zhang N
Int J Chron Obstruct Pulmon Dis; 2020; 15():2379-2388. PubMed ID: 33061355
[TBL] [Abstract][Full Text] [Related]
3. The usefulness of soluble receptor for advanced glycation end-products in the identification of COPD frequent exacerbator phenotype.
Miłkowska-Dymanowska J; Białas AJ; Szewczyk K; Kurmanowska Z; Górski P; Piotrowski WJ
Int J Chron Obstruct Pulmon Dis; 2018; 13():3879-3884. PubMed ID: 30568439
[TBL] [Abstract][Full Text] [Related]
4. Airway IL-1β and Systemic Inflammation as Predictors of Future Exacerbation Risk in Asthma and COPD.
Fu JJ; McDonald VM; Baines KJ; Gibson PG
Chest; 2015 Sep; 148(3):618-629. PubMed ID: 25950204
[TBL] [Abstract][Full Text] [Related]
5. COPD Exacerbator Phenotype is Inversely Associated with Current Smoking But Not with Haptoglobin Phenotype.
Tal S; Adir Y; Stein N; Shalom H; Lache O; Levy A; Shteinberg M
Isr Med Assoc J; 2019 Jan; 21(1):19-23. PubMed ID: 30685900
[TBL] [Abstract][Full Text] [Related]
6. Characterization Associated with the Frequent Severe Exacerbator Phenotype in COPD Patients.
Wu YK; Su WL; Yang MC; Chen SY; Wu CW; Lan CC
Int J Chron Obstruct Pulmon Dis; 2021; 16():2475-2485. PubMed ID: 34511892
[TBL] [Abstract][Full Text] [Related]
7. Is serum iron responsive protein-2 level associated with pulmonary functions and frequent exacerbator phenotype in COPD?
Acet Öztürk NA; Görek Dilektaşlı A; Demirdöğen E; Coşkun F; Ursavaş A; Karadağ M; Kunt Uzaslan E
Tuberk Toraks; 2020 Sep; 68(3):252-259. PubMed ID: 33295723
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Functional Lung Parameters Associated With Frequent Exacerbator Phenotype in Subjects With Severe COPD.
Capozzolo A; Carratù P; Dragonieri S; Falcone VA; Quaranta VN; Liotino V; D'Alba G; Castellana G; Resta O
Respir Care; 2017 May; 62(5):572-578. PubMed ID: 28270543
[TBL] [Abstract][Full Text] [Related]
9. Factors Associated with the Non-Exacerbator Phenotype of Chronic Obstructive Pulmonary Disease.
Bouhuis D; Giezeman M; Hasselgren M; Janson C; Kisiel MA; Lisspers K; Montgomery S; Nager A; Sandelowsky H; Ställberg B; Sundh J
Int J Chron Obstruct Pulmon Dis; 2023; 18():483-492. PubMed ID: 37051115
[TBL] [Abstract][Full Text] [Related]
10. A mixed phenotype of airway wall thickening and emphysema is associated with dyspnea and hospitalization for chronic obstructive pulmonary disease.
Van Tho N; Ogawa E; Trang le TH; Ryujin Y; Kanda R; Nakagawa H; Goto K; Fukunaga K; Higami Y; Seto R; Wada H; Yamaguchi M; Nagao T; Lan le TT; Nakano Y
Ann Am Thorac Soc; 2015 Jul; 12(7):988-96. PubMed ID: 25844673
[TBL] [Abstract][Full Text] [Related]
11. Differences in systemic adaptive immunity contribute to the 'frequent exacerbator' COPD phenotype.
Geerdink JX; Simons SO; Pike R; Stauss HJ; Heijdra YF; Hurst JR
Respir Res; 2016 Oct; 17(1):140. PubMed ID: 27793198
[TBL] [Abstract][Full Text] [Related]
12. Defining the "Frequent Exacerbator" Phenotype in COPD: A Hypothesis-Free Approach.
Le Rouzic O; Roche N; Cortot AB; Tillie-Leblond I; Masure F; Perez T; Boucot I; Hamouti L; Ostinelli J; Pribil C; Poutchnine C; Schück S; Pouriel M; Housset B
Chest; 2018 May; 153(5):1106-1115. PubMed ID: 29054347
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of roflumilast in the COPD frequent exacerbator phenotype.
Wedzicha JA; Rabe KF; Martinez FJ; Bredenbröker D; Brose M; Goehring UM; Calverley PMA
Chest; 2013 May; 143(5):1302-1311. PubMed ID: 23117188
[TBL] [Abstract][Full Text] [Related]
14. Serum CCL-18 level is a risk factor for COPD exacerbations requiring hospitalization.
Dilektasli AG; Demirdogen Cetinoglu E; Uzaslan E; Budak F; Coskun F; Ursavas A; Ercan I; Ege E
Int J Chron Obstruct Pulmon Dis; 2017; 12():199-208. PubMed ID: 28115842
[TBL] [Abstract][Full Text] [Related]
15. The characteristics of the frequent exacerbator with chronic bronchitis phenotype and non-exacerbator phenotype in patients with chronic obstructive pulmonary disease: a meta-analysis and system review.
Wu JJ; Xu HR; Zhang YX; Li YX; Yu HY; Jiang LD; Wang CX; Han M
BMC Pulm Med; 2020 Apr; 20(1):103. PubMed ID: 32326924
[TBL] [Abstract][Full Text] [Related]
16. Standardized airway wall thickness Pi10 from routine CT scans of COPD patients as imaging biomarker for disease severity, lung function decline, and mortality.
Kahnert K; Jörres RA; Kauczor HU; Alter P; Trudzinski FC; Herth F; Jobst B; Weinheimer O; Nauck S; Mertsch P; Kauffmann-Guerrero D; Behr J; Bals R; Watz H; Rabe KF; Welte T; Vogelmeier CF; Biederer J
Ther Adv Respir Dis; 2023; 17():17534666221148663. PubMed ID: 36718763
[TBL] [Abstract][Full Text] [Related]
17. Severity of chronic obstructive pulmonary disease with 'exacerbator with emphysema phenotype' is associated with potential biomarkers.
Hao W; Li M; Zhang Y; Zhang C; Wang P
Postgrad Med J; 2020 Jan; 96(1131):28-32. PubMed ID: 31375557
[TBL] [Abstract][Full Text] [Related]
18. Airway gene expression of IL-1 pathway mediators predicts exacerbation risk in obstructive airway disease.
Baines KJ; Fu JJ; McDonald VM; Gibson PG
Int J Chron Obstruct Pulmon Dis; 2017; 12():541-550. PubMed ID: 28223794
[TBL] [Abstract][Full Text] [Related]
19. A predictive model for frequent exacerbator phenotype of acute exacerbations of chronic obstructive pulmonary disease.
Zhang Y; Zheng SP; Hou YF; Jie XY; Wang D; Da HJ; Li HX; He J; Zhao HY; Liu JH; Ma Y; Qiang ZH; Li W; Zhang M; Shan H; Wu YY; Shi HY; Zeng L; Sun X; Liu Y
J Thorac Dis; 2023 Dec; 15(12):6502-6514. PubMed ID: 38249857
[TBL] [Abstract][Full Text] [Related]
20. Adiposity influences airway wall thickness and the asthma phenotype of HIV-associated obstructive lung disease: a cross-sectional study.
Barton JH; Ireland A; Fitzpatrick M; Kessinger C; Camp D; Weinman R; McMahon D; Leader JK; Holguin F; Wenzel SE; Morris A; Gingo MR
BMC Pulm Med; 2016 Aug; 16(1):111. PubMed ID: 27488495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
